Posted in | News | Nanoenergy | Nanobusiness

A123 Systems Enters into Collaborative Business Development Agreement with IHI

A123 Systems (Nasdaq:AONE) and IHI Corporation (TYO:7013) announced today that they have entered into a collaborative business development agreement to serve potential customers in the Japanese transportation, industrial and marine markets. Under the terms of a joint marketing agreement, the two companies will pursue new customer opportunities in energy storage in the Japanese market.

IHI is one of the largest heavy industry equipment makers in Japan with long-standing business operations in the automotive, utilities, marine and aerospace industries. With over 24,000 employees around the world and over 155 years of history, IHI customers include major Japanese car makers Toyota, Honda, Nissan, Mazda, Suzuki and Mitsubishi. The company is a tier one turbo charger supplier to truck and auto makers all over the world.

"We are very pleased to have found such a strong partner in IHI as we begin to identify a portfolio of energy storage business opportunities in the Japanese market," said David Vieau, A123 Systems' president and chief executive officer. "We believe their confidence in our technology is another important validation of both our product offerings and our business strategy as a vertically integrated supplier of lithium ion batteries and battery systems. We continue to diversify our business pipeline by designing and producing products for multiple customer applications and can now more efficiently bring these technologies to the important Japanese market."

"Our collaboration with A123 is a significant step forward in our commitment to the application of technology that can help reduce carbon emissions. We believe that A123 has excellent lithium ion battery technology and our strategic alignment will allow us to collaborate in multiple market segments and technology applications," said Kazuaki Kama, IHI Corporation's president and chief executive officer.

About A123 Systems

A123 Systems, Inc. (Nasdaq:AONE) develops and manufactures advanced lithium ion batteries and battery systems for the transportation, electric grid services and consumer markets. Headquartered in Massachusetts and founded in 2001, A123 was funded initially with a $100,000 grant from the U.S. Department of Energy. A123 Systems' proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology. Among the companies selecting A123 batteries, battery systems and technology in the fields of transportation, grid energy storage and consumer products are Chrysler, Shanghai Automotive Industry Corporation, AES Energy Storage, LLC and The Black & Decker Corporation.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Wanxiang A123 Systems Corp. (2019, March 18). A123 Systems Enters into Collaborative Business Development Agreement with IHI. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=14364.

  • MLA

    Wanxiang A123 Systems Corp. "A123 Systems Enters into Collaborative Business Development Agreement with IHI". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=14364>.

  • Chicago

    Wanxiang A123 Systems Corp. "A123 Systems Enters into Collaborative Business Development Agreement with IHI". AZoNano. https://www.azonano.com/news.aspx?newsID=14364. (accessed November 21, 2024).

  • Harvard

    Wanxiang A123 Systems Corp. 2019. A123 Systems Enters into Collaborative Business Development Agreement with IHI. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=14364.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.